The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following the advice of a recently fired panel of government vaccine advisers. The ...

The panel of vaccine experts was fired in June by U.S. Health Secretary Robert F Kennedy Jr. The recommendations were also accepted by Kennedy, in the absence of the director of the agency, the ...

The U.S. CDC recommends RSV vaccines for high-risk adults aged 50-59, endorsing the views of the former vaccine advisory panel. Read more here.

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk ...

RSV is the leading cause of hospitalizations among newborns and younger children. Among those under age 5, the CDC reports between 58,000 and 80,000 hospitalizations a year. RFK Jr.'s vaccine ...

An RSV vaccine during pregnancy and another antibody shot called clesrovimab that can be given to newborns have previously been approved by the Food and Drug Administration and recommended by the ...

CDC vaccine advisers recommend Merck’s RSV therapy for babies The vote was the first for the new members of the committee, who had been handpicked by health secretary Robert F. Kennedy Jr. Merck ...